B. Sözeri Et Al. , "The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients.," Clinical and experimental rheumatology , vol.39, no.5, pp.118-123, 2021
Sözeri, B. Et Al. 2021. The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients.. Clinical and experimental rheumatology , vol.39, no.5 , 118-123.
Sözeri, B., Sönmez, H. E., Karadağ, Ş. G., Bağlan, E., Öztürk, K., Çakan, M., ... Demir, F.(2021). The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients.. Clinical and experimental rheumatology , vol.39, no.5, 118-123.
Sözeri, Betül Et Al. "The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients.," Clinical and experimental rheumatology , vol.39, no.5, 118-123, 2021
Sözeri, Betül Et Al. "The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients.." Clinical and experimental rheumatology , vol.39, no.5, pp.118-123, 2021
Sözeri, B. Et Al. (2021) . "The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients.." Clinical and experimental rheumatology , vol.39, no.5, pp.118-123.
@article{article, author={Betül Sözeri Et Al. }, title={The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients.}, journal={Clinical and experimental rheumatology}, year=2021, pages={118-123} }